Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 9—September 2007


Parenteral Transmission of the Novel Human Parvovirus PARV4

Peter Simmonds*Comments to Author , Ashleigh Manning*, Rachel Kenneil*, Frances W. Carnie†, and Jeanne E. Bell†
Author affiliations: *University of Edinburgh, Edinburgh, Scotland, United Kingdom; †Western General Hospital, Edinburgh, Scotland, United Kingdom;

Main Article

Table 2

Concordance of parvovirus B19 and PARV4 detection between bone marrow and lymphoid tissue*

Virus detected and risk group Lymphoid tissue
Positive Negative
B19 (all risk groups)
Bone marrow
Positive 27 1
Negative 3 29
PARV4 (IDUs and persons with hemophilia)
Bone marrow
Positive 14 1
Negative 2 21

*IDUs, injection drug users.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO